pubmed-article:21705065 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C0011854 | lld:lifeskim |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:21705065 | lifeskim:mentions | umls-concept:C1518527 | lld:lifeskim |
pubmed-article:21705065 | pubmed:issue | 9786 | lld:pubmed |
pubmed-article:21705065 | pubmed:dateCreated | 2011-7-11 | lld:pubmed |
pubmed-article:21705065 | pubmed:abstractText | Poor glycaemic control is associated with microvascular and macrovascular complications in type 1 diabetes, but whether glycaemic control is associated with heart failure in such patients is not known. We aimed to assess this association in a large cohort of patients with type 1 diabetes identified from the Swedish national diabetes registry. | lld:pubmed |
pubmed-article:21705065 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21705065 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21705065 | pubmed:language | eng | lld:pubmed |
pubmed-article:21705065 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21705065 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:21705065 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21705065 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21705065 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21705065 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21705065 | pubmed:month | Jul | lld:pubmed |
pubmed-article:21705065 | pubmed:issn | 1474-547X | lld:pubmed |
pubmed-article:21705065 | pubmed:author | pubmed-author:Gudbjörnsdott... | lld:pubmed |
pubmed-article:21705065 | pubmed:author | pubmed-author:RosengrenAnni... | lld:pubmed |
pubmed-article:21705065 | pubmed:author | pubmed-author:SvenssonAnn-M... | lld:pubmed |
pubmed-article:21705065 | pubmed:author | pubmed-author:LindMarcusM | lld:pubmed |
pubmed-article:21705065 | pubmed:author | pubmed-author:OlssonMaritaM | lld:pubmed |
pubmed-article:21705065 | pubmed:author | pubmed-author:BouniasIoanni... | lld:pubmed |
pubmed-article:21705065 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ltd. All rights reserved. | lld:pubmed |
pubmed-article:21705065 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21705065 | pubmed:day | 9 | lld:pubmed |
pubmed-article:21705065 | pubmed:volume | 378 | lld:pubmed |
pubmed-article:21705065 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21705065 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21705065 | pubmed:pagination | 140-6 | lld:pubmed |
pubmed-article:21705065 | pubmed:dateRevised | 2011-10-3 | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:meshHeading | pubmed-meshheading:21705065... | lld:pubmed |
pubmed-article:21705065 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21705065 | pubmed:articleTitle | Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. | lld:pubmed |
pubmed-article:21705065 | pubmed:affiliation | Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com | lld:pubmed |
pubmed-article:21705065 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21705065 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21705065 | lld:pubmed |